Supplementary Table S1 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
Supplementary Table S1 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
Dong Liang, Hareesh B. Nair, Megharani Mahajan, Huan Xie et al.
Topics
Glycosylation and Glycoproteins Research
article
Supplementary Table S1 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer
Dong Liang, Hareesh B. Nair, Megharani Mahajan, Huan Xie, John R. Sanchez, Jessica D. Johnson, Sridharan Jayamohan, Yang Wang, Suryavathi Viswanadhapalli, Manjeet K. Rao, Gangadhara R. Sareddy, Panneerdoss Subbarayalu, K.V. Dileep, Ratna K. Vadlamudi, Alondra L. Rodriguez Sanchez